Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Payables: 2023-2024

Historic Payables for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $6.5 million.

  • CG Oncology's Payables fell 18.85% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.6 million, marking a year-over-year increase of 10.31%. This contributed to the annual value of $6.5 million for FY2024, which is 101.02% up from last year.
  • Latest data reveals that CG Oncology reported Payables of $6.5 million as of FY2024, which was up 101.02% from $3.2 million recorded in FY2023.
  • Over the past 5 years, CG Oncology's Payables peaked at $6.5 million during FY2024, and registered a low of $3.2 million during FY2023.
  • Moreover, its 2-year median value for Payables was $4.9 million (2023), whereas its average is $4.9 million.
  • Data for CG Oncology's Payables shows a peak YoY soared of 101.02% (in 2024) over the last 5 years.
  • CG Oncology's Payables (Yearly) stood at $3.2 million in 2023, then surged by 101.02% to $6.5 million in 2024.